
ADM will end production of dry lysine in the first half of 2021 and will complete work in progress. The company said it will focus solely on liquid and encapsulated lysine, citing market conditions that have eroded because global industry capacity has expanded faster than demand.
Exiting a major dry lysine producer removes capacity from an oversupplied market, which may give modest support to dry lysine prices. The shift to liquid and encapsulated products means the impact on feed buyers depends on how quickly the dry supply leaves the market.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.